FDA Accepts Ivonescimab Application for EGFR Lung Cancer – Cure Today

Reference. “HARMONi phase 3 trial of ivonescimab in EGFR-mutated non-small cell lung cancer” News Release. iScience. Jan 29, 2026. Editor’s note …